Delivery Order SPE2DB20D3303-SPE2DB24FZ4A2
Award Date 4/8/24
Potential Completion Date 4/9/24
Potential Value $1.1K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a $2,434.19 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of MOUNJARO 5 MG/0.5 ML PEN 0.5ML pharmaceuticals. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary contract vehicle for AmerisourceBergen to deliver pharmaceutical products and medical supplies to DLA Troop Support...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,052.00 to the prime contractor, AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the provision of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide MOUNJARO 15 MG/0.5 ML PEN 0.5ML pharmaceutical products. The $2,400.00 contract has an ultimate completion date of April 8, 2024. AmerisourceBergen Drug Corp is the prime contractor and has an active indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, to deliver a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $1,039.68 and a performance period through March 15, 2024. This delivery order was issued under an existing indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with DLA, which serves as the primary vehicle...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $2,630.00 firm fixed price delivery order contract for the supply of MOUNJARO 5 MG/0.5 ML PEN 0.5ML pharmaceuticals. This delivery order falls under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
- The U.S. Defense Logistics Agency (DLA) awarded a $2,630.00 firm fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of MOUNJARO 15 MG/0.5 ML PEN 0.5ML. This order was placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide MOUNJARO 10 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract, valued at $1,323.67, has an ultimate completion date of March 18, 2024. AmerisourceBergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which...
- This is a $1,582.49 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The order has an ultimate completion date of April 3, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as a primary vehicle for providing a comprehensive range of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide MOUNJARO 5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The $10,170.76 award has a completion date of March 7, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,360.45 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MOUNJARO 12.5 MG/0.5 ML PEN 0.5ML. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical division, which enables the efficient procurement of a comprehensive range of pharmaceutical products and medical supplies to support...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB24FZ4A2Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $1,052.00 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML. This delivery order was placed under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that AmerisourceBergen Drug Corp holds with DLA to provide pharmaceutical products and medical supplies to support military treatment programs and facilities worldwide. The contract has an ultimate completion date of April 9, 2024, and was awarded on April 8, 2024. No set-aside designations were used for this contract.
Generated 7/8/24, 9:30 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 4/8/24 |